CELLINK and partner Prellis Biologics awarded Merck Innovation Award for cutting-edge technology designed to empower pharmaceutical research.

Booking.com

CELLINK began collaborating with Prellis Biologics to develop the Holograph X bioprinter in 2018, and the technology was recently recognized enabling innovative capabilities for the pharmaceutical industry.
The Holograph X, a bioprinter that leverages high-resolution holographic stereolithography to bioprint small structures, earned CELLINK a top honor as an innovative medical device with the potential to change what’s possible in pharmaceutical medicine.

In the award announcement, Merck senior investigator Tim Rhodes recognized CELLINK and California-based development partner Prellis

Booking.com

Source: CELLINK and partner Prellis Biologics awarded Merck Innovation Award for cutting-edge technology designed to empower pharmaceutical research.

Booking.com

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.